370 related articles for article (PubMed ID: 8446256)
1. Progression of chronic adriamycin nephropathy in leukopenic rats.
Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
[TBL] [Abstract][Full Text] [Related]
2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
3. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
4. Exposure to hydrocarbons and renal disease: an experimental animal model.
Mutti A; Coccini T; Alinovi R; Toubeau G; Broeckaert F; Bergamaschi E; Mozzoni P; Nonclercq D; Bernard A; Manzo L
Ren Fail; 1999; 21(3-4):369-85. PubMed ID: 10416216
[TBL] [Abstract][Full Text] [Related]
5. A protective role for programmed death 1 in progression of murine adriamycin nephropathy.
Qin XH; Lee VW; Wang YP; Zheng GP; Wang Y; Alexander SI; Harris DC
Kidney Int; 2006 Oct; 70(7):1244-50. PubMed ID: 16900095
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
Barretti P; Viero RM; Soares VA
Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
[TBL] [Abstract][Full Text] [Related]
7. Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy.
Wang Y; Wang Y; Feng X; Bao S; Yi S; Kairaitis L; Tay YC; Rangan GK; Harris DC
Kidney Int; 2001 Mar; 59(3):975-84. PubMed ID: 11231352
[TBL] [Abstract][Full Text] [Related]
8. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
9. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan.
Mihailovic-Stanojevic N; Jovovic D; Miloradovic Z; Grujic-Milanovic J; Jerkic M; Markovic-Lipkovski J
Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260
[TBL] [Abstract][Full Text] [Related]
10. Sex difference in progression of adriamycin-induced nephropathy in rats.
Sakemi T; Ohtsuka N; Tomiyoshi Y; Morito F
Am J Nephrol; 1996; 16(6):540-7. PubMed ID: 8955769
[TBL] [Abstract][Full Text] [Related]
11. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression.
Liu Y; Ji Z
J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594
[TBL] [Abstract][Full Text] [Related]
12. Protracted high-dose interferon gamma therapy for chronic experimental nephropathy.
Ginevri F; Bergamaschi E; Mutti A; Trivelli A; Salvidio G; Fabbretti G; Perfumo F; Ghiggeri GM
Life Sci; 1994; 54(4):PL45-50. PubMed ID: 8289579
[TBL] [Abstract][Full Text] [Related]
13. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria: detection and role in native renal disease progression.
Gorriz JL; Martinez-Castelao A
Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.
Rangan GK; Wang Y; Tay YC; Harris DC
Kidney Int; 1999 Jul; 56(1):118-34. PubMed ID: 10411685
[TBL] [Abstract][Full Text] [Related]
16. Glomerular basement membrane anionic sites in adriamycin nephropathy: effect of saline loading and nitric oxide modulation.
Hertzan-Levy S; Fish R; Skutelsky E; Wollman Y; Chernichovsky T; Polak-Charcon S; Schwartz D; Blum M; Cabili S; Iaina A
Nephron; 2000 Apr; 84(4):354-61. PubMed ID: 10754413
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin-induced glomerulosclerosis in the rat.
Bertani T; Rocchi G; Sacchi G; Mecca G; Remuzzi G
Am J Kidney Dis; 1986 Jan; 7(1):12-9. PubMed ID: 3510531
[TBL] [Abstract][Full Text] [Related]
18. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
19. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2000 Oct; 58(4):1797-804. PubMed ID: 11012915
[TBL] [Abstract][Full Text] [Related]
20. Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.
Liu H; Sun W; Gu LB; Tu Y; Yu BY; Hu H
Chin J Integr Med; 2017 Apr; 23(4):279-287. PubMed ID: 26453563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
